MediciNova, Inc. (MNOV) is an innovative biotherapeutics company engaged in the development of therapies for fibrotic, inflammatory, and neurodegenerative disorders. The product candidate MN-166 is
MediciNova, Inc. (MNOV), a biopharmaceutical company, has plunged 1.81% in aftermarket trading session. Consequently, MNOV is trading at $4.41 at the time of the writing.
MediciNova, Inc. (MNOV) stock prices were down by a marginal 0.96% as of the market closing on July 2nd, 2021, bringing the price per share
In premarket trading hours, the shares of Medical Nova Inc. (MNOV) have risen 54.26% to $5.80. Last trading session ended with the stock at $3.76,
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.